# Award #75N93026D00014

Multi-Year IDV Contract for Antimicrobial Activity Assessment to University of Pennsylvania

**Buyer:** National Institutes of Health

**Award Amount:** $2,500.00
**Ceiling:** $2,500.00

**Awarded:** September 30, 2026
**Period of Performance:** Sep 30, 2026 - Sep 29, 2036

**Identifier:** 75N93026D00014
**NAICS:** 541714

This award represents a definitive Indefinite Delivery Vehicle (IDV) contract granted to The Trustees of the University of Pennsylvania, a prominent research institution known for its contributions to biomedical science. The contract focuses on procuring specialized scientific services for in vitro assessment of antimicrobial activity, aimed at advancing research and development in this critical area. The significance of this agreement lies in its potential to support public health initiatives by enhancing the understanding and evaluation of antimicrobial agents, which are vital in combating infectious diseases. The scope of work encompasses comprehensive laboratory testing and analysis related to antimicrobial efficacy, conducted over a substantial multi-year timeframe. The award was made through a competitive process, underscoring the university's capability and expertise in delivering high-quality research services. The contract's performance period spans a decade, establishing a long-term partnership to support ongoing scientific investigations. No specific contract vehicle, acquisition programs, subcontractors, or prior related contracts have been detailed for this award.

### Description

IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)

[View original record](https://www.usaspending.gov/award/CONT_IDV_75N93026D00014_7529)